B. Liu

488 total citations
28 papers, 379 citations indexed

About

B. Liu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, B. Liu has authored 28 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in B. Liu's work include Colorectal Cancer Treatments and Studies (6 papers), Cancer Genomics and Diagnostics (3 papers) and Gastric Cancer Management and Outcomes (3 papers). B. Liu is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Cancer Genomics and Diagnostics (3 papers) and Gastric Cancer Management and Outcomes (3 papers). B. Liu collaborates with scholars based in China, United States and Australia. B. Liu's co-authors include Rui Guo, Mi Yang, Li Zhang, Xiaoshun Jiang, Bingzhu Hua, Yaqiong Tang, Xuebing Feng, Lingyun Sun, Mengshu Cao and Hao Zhang and has published in prestigious journals such as Advanced Materials, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

B. Liu

22 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
B. Liu China	6	143	85	82	77	61	28	379
Wenbin Dang United States	12	262 1.8×	116 1.4×	130 1.6×	136 1.8×	29 0.5×	13	581
Irene Kee Singapore	11	253 1.8×	18 0.2×	203 2.5×	120 1.6×	40 0.7×	16	551
Ebel H. E. Pieters Netherlands	10	346 2.4×	102 1.2×	200 2.4×	243 3.2×	41 0.7×	11	593
Md. Muniruzzaman Japan	9	333 2.3×	82 1.0×	296 3.6×	136 1.8×	40 0.7×	12	669
Yu. G. Suzdaltseva Russia	10	146 1.0×	112 1.3×	45 0.5×	247 3.2×	23 0.4×	25	553
Mariarita Laforgia Italy	12	120 0.8×	58 0.7×	215 2.6×	94 1.2×	11 0.2×	22	571
Kristie M. Tevis United States	6	182 1.3×	65 0.8×	207 2.5×	94 1.2×	64 1.0×	6	513
Eric Hsu United States	12	105 0.7×	108 1.3×	37 0.5×	319 4.1×	16 0.3×	21	628
Henrike Caysa Germany	13	225 1.6×	64 0.8×	237 2.9×	211 2.7×	14 0.2×	15	662
Yaohua Wei China	18	405 2.8×	80 0.9×	351 4.3×	326 4.2×	30 0.5×	32	851

Countries citing papers authored by B. Liu

Since Specialization

Citations

This map shows the geographic impact of B. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Liu more than expected).

Fields of papers citing papers by B. Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Liu. The network helps show where B. Liu may publish in the future.

Co-authorship network of co-authors of B. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of B. Liu. A scholar is included among the top collaborators of B. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Liu. B. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, B., et al.. (2025). Improving soil properties and Sesbania growth through combined organic amendment strategies in a coastal saline-alkali soil. Journal of Environmental Management. 374. 124041–124041. 3 indexed citations

Huang, Hao, Junsheng Li, Yanling Zhang, et al.. (2025). Liriodendron attenuates intestinal fibrosis and inflammation in mice with radiation proctopathy. Chinese Medicine. 20(1). 181–181.

Liu, B., et al.. (2025). Transformation from EGFR-mutant lung adenocarcinoma to small-cell lung cancer: from clonal evolution to lineage reprogramming. Cancer Treatment Reviews. 141. 103044–103044.

Zhu, Juan, Yida Huang, Xue Li, et al.. (2025). Metabolic signatures for gastric cancer diagnosis and mechanistic insights: a multicenter study. EMBO Molecular Medicine. 17(12). 3355–3376.

Chai, Jianyuan, et al.. (2024). 1467P Efficacy and safety of disitamab vedotin (RC48) combined with camrelizumab and S-1 for neoadjuvant therapy of locally advanced gastric cancer with HER2 overexpression: Preliminary results of a prospective, single-arm, phase II study. Annals of Oncology. 35. S908–S908. 3 indexed citations

Liu, B., et al.. (2024). A novel model for predicting prognosis in patients with idiopathic pulmonary fibrosis based on endoplasmic reticulum stress‐related genes. Cell Biology International. 48(4). 483–495. 3 indexed citations

Zhang, Meng, Lixia Liu, B. Liu, et al.. (2024). Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis. Frontiers in Immunology. 15. 1400744–1400744. 14 indexed citations

Ye, Ding, et al.. (2024). Lifestyle and genetic predisposition are associated with incident irritable bowel syndrome: A population-based prospective cohort study. Clinical Nutrition. 43(6). 1544–1550.

Ji, Jin, Qi Zhang, Yong Ji, et al.. (2024). Comparison of robotic assisted and laparoscopic radical resection for rectal cancer with or without left colic artery preservation. Scientific Reports. 14(1). 28113–28113. 1 indexed citations

10.

Song, Jiangdian, Jie Zhang, Wenxiang Lin, et al.. (2024). PET/CT deep learning prognosis for treatment decision support in esophageal squamous cell carcinoma. Insights into Imaging. 15(1). 161–161. 1 indexed citations

11.

Gao, Qi, et al.. (2024). An Overview of Research Advances in Oncology Regarding the Transcription Factor ATF4. Current Drug Targets. 26(1). 59–72. 2 indexed citations

12.

Jiang, Zhenxing, et al.. (2022). Predicting the probability of malignant pathological type of kidney cancer based on mass size: A retrospective study. Progrès en Urologie. 32(12). 849–855. 2 indexed citations

13.

Ren, Zhenggang, Jia Fan, Jian Xu, et al.. (2020). LBA2 Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2. Annals of Oncology. 31. S1287–S1287. 25 indexed citations

14.

Shen, Lin, J. Li, Nong Xu, et al.. (2020). 1445P CS1001, an anti-PD-L1 antibody, combined with standard of care (SOC) chemotherapy for first line (1L) advanced GC/GEJ and ESCC: Preliminary results from 2 phase Ib cohorts of CS1001-101 study. Annals of Oncology. 31. S909–S909. 7 indexed citations

15.

Yan, Jing, Ju Dong Yang, Wei Ren, et al.. (2018). Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 102(3). e374–e375. 2 indexed citations

16.

Li, Rutian, et al.. (2017). Camouflaging iRGD-EGFR anchored human cytotoxic T-lymphocyte membranes to the surface of nanoparticles combined with low-dose irradiation: New approach to enhance drug-delivery targeting in gastric cancer. Annals of Oncology. 28. v13–v13.

17.

Wei, Jia, Ying Huang, Nan Wu, Lixia Yu, & B. Liu. (2016). KRAS mutation and protein levels in gastric cancer patients and response to MEK inhibitors. Annals of Oncology. 27. vi214–vi214. 2 indexed citations

18.

Zhang, Hao, Mengshu Cao, Yaqiong Tang, et al.. (2011). Efficacy of allogeneic mesenchymal stem cell transplantation in patients with drug-resistant polymyositis and dermatomyositis. Annals of the Rheumatic Diseases. 70(7). 1285–1288. 63 indexed citations

19.

Wu, Zhongxue, et al.. (2010). Results of Endovascular Management for Mid-Basilar Artery Aneurysms. Interventional Neuroradiology. 16(3). 249–254. 5 indexed citations

20.

Wei, Jia, et al.. (2007). ERCC1 mRNA expression and XRCC1 polymorphism as predictive factors for overall survival in gastric cancer patients receiving platinum based chemotherapy. Journal of Clinical Oncology. 25(18_suppl). 2512–2512. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact